检索结果-南通市图书馆

印度喜马拉亚东部3个经济竹种的分布、生长和生产力(英文)

在线全文

学校读者我要写书评

暂无评论

世界竹藤通讯 2004年第3期2卷 22-32页

作者： B.P.bhatt L.B.Singha Kundan Singh M.S.Sachan Agroforestry Division ICAR Research Complex for N.E.H.RegionUmroi Road Umiam MeghalayaIndiaAgroforestry DivisionICAR Research Complex for N.E.H.RegionUmroi Road Umiam MeghalayaIndiaAgroforestry DivisionICAR Research Complex for N.E.H.RegionUmroi Road Umiam MeghalayaIndiaAgroforestry DivisionICAR Research Complex for N.E.H.RegionUmroi Road Umiam MeghalayaIndia

对印度喜马拉亚东部3个州的经济竹种的分布、生长和生产力进行了研究。在梅加拉亚那邦,发现了牡竹属、巴苦竹和梨竹属3个经济竹种。巴苦竹是在米佐拉姆的记载,方竹属和牡竹属是在锡金记载的笋用竹。所有竹种除野生外均在庭院中栽培。据... 详细信息

对印度喜马拉亚东部3个州的经济竹种的分布、生长和生产力进行了研究。在梅加拉亚那邦,发现了牡竹属、巴苦竹和梨竹属3个经济竹种。巴苦竹是在米佐拉姆的记载,方竹属和牡竹属是在锡金记载的笋用竹。所有竹种除野生外均在庭院中栽培。据观察,竹子的产量与海拔的变化密切相关,巴苦竹最大产量出现在低海拔的而非高海拔的林分中。牡竹在梅加拉亚邦每丛生长69株,每公顷1839株,大大高于庭院种植的低海拔株数(每丛16株,每公顷303株)。而在天然林中,在高海拔总株数为每丛29株,每公顷1186株,在低海拔中每丛22株,每公顷178株。

关键词：经济竹种生产力生长分布东部印度低海拔庭院种植牡竹属高海拔公顷苦竹笋用竹天然林产量株数竹子林分梅梨

在线全文

学校读者我要写书评

暂无评论

裸金属支架置入术后再狭窄不是良性临床疾病

世界核心医学期刊文摘（心脏病学分册） 2006年第11期2卷 14-15页

作者： John J.M. Chew D.P. D.L. bhatt 罗亮 The Department of Cardiovascular Medicine The Cleveland Clinic Foundation Cleveland OH United States Dr.

Background: Restenosis after percutaneous coronary intervention(PCI) has been thought to present in a stable manner as exertional angina. However, the presentation of in-stent restenosis(ISR) is not well-studied. We hypothesized that a substantial proportion of bare metal ISR presents as acute coronary syndromes. We aimed to characterize the severity of the clinical presentation of ISR. Methods: We searched our PCI database for all cases of PCI for bare metal ISR occurring between May 1999 and September 2003. Multivessel interventions were excluded. In-stent restenosis presentation was classified into three categories:(1) myocardial infarction(MI),(2) unstable angina requiring hospitalization before angiography, and(3) exertional angina. Routine angiographic screening after initial stent placement was not performed, so ISR episodes were clinical, rather than angiographic, ISR. Results: We identified 1186 cases of bare metal ISR in 984 patients. Median age was 63, 72%were male, and 36%had diabetes. Of the ISR episodes, 9.5%presented as acute MI(7.3%as non-ST-segment elevation MI and 2.2%as ST-segment elevation MI), 26.4%as unstable angina requiring hospitalization before angiography, and 64.1%as exertional angina. Conclusions: More than one third of bare metal ISR episodes presented as MI or unstable angina requiring hospitalization. The acuity of the clinical presentation of bare metal ISR appears to be more severe than has been previously thought. Aggressive efforts, such as drug-eluting stents to decrease the incidence of unstable angina due to bare metal ISR, are warranted.

关键词：裸金属支架再狭窄劳力型心绞痛不稳定型心绞痛药物洗脱支架支架置入术血管造影临床标准血管

动脉粥样硬化血栓形成门诊患者心血管危险因素的国际患病率、认识和治疗

在线全文

学校读者我要写书评

暂无评论

世界核心医学期刊文摘(神经病学分册) 2006年第4期 2-3页

作者： bhatt D.L. Gabriel Steg P. Magnus Ohman E. 王鹏 Cleveland Clinic Foundation 9500 Euclid Ave Cleveland OH 44195 United States.Dr

Context:Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the globe. To date, no single international database has characterized the atherosclerosis risk factor profile or treatment intensity of individuals with atherothrombosis. Objective: To determine whether atherosclerosis risk factor prevalence and treatment would demonstrate comparable patterns in many countries around the world. Design, Setting, and Participants: The Reduction of Atherothrombosis for Continued Health (REACH) Registry collected data on atherosclerosis risk factors and treatment. A total of 67 888 patients aged 45 years or older from 5473 physician practices in 44 countries had either established arterial disease (coronary artery disease [CAD], n = 40 258; cerebrovascular disease, n = 18843; peripheral arterial disease, n = 8273) or 3 or more risk factors for atherothrombosis (n = 12 389) between 2003 and 2004. Main Outcome Measures: Baseline prevalence of atherosclerosis risk factors, medication use, and degree of risk factor control. Results: Atherothrombotic patients throughout the world had similar risk factor profiles: a high proportion with hypertension (81.8% ), hypercholesterolemia (72.4% ), and diabetes (44.3% ). The prevalence of overweight (39.8% ), obesity (26.6% ), and morbid obesity (3.6% ) were similar in most geographic locales, but was highest in North America (overweight: 37.1% , obese: 36.5% , and morbidly obese: 5.8% ; P < .001 vs other regions). Patients were generally undertreated with statins (69.4% overall; range: 56.4% for cerebrovascular disease to 76.2% for CAD), antiplatelet agents (78.6% overall; range: 53.9% for ≥ 3 risk factors to 85.6% for CAD), and other evidence-based risk reduction therapies. Current tobacco use in patients with established vascular disease was substantial (14.4% ). Undertreated hypertension (50.0% with elevated blood pressure at baseline), undiagnosed hyperglycemia (4.9% ), and impaired fasting glucose (36

关键词：动脉粥样硬化血栓形成患者心血管危险因素患病率

粉红之城全球宝石首饰力量之祖母绿切割和交易中心

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

中国宝石 2017年第4期26卷 114-121页

作者： Andrew Lucas Nirupa bhatt Manoj Singhania Kashish Sachish Sachdeva Tao Hsu Pedro Padua 丽茹

在彩色宝石由矿山到市场的这个过程，全球有几个重要的中心，如中国、泰国、斯里兰卡和印度斋普尔。每个中心都有它的属性、定位和挑战。2015年，美国宝石学院的一支田野考察队考察了印度斋普尔，全方位走访了其宝石和首饰业：彩色宝石... 详细信息

在彩色宝石由矿山到市场的这个过程，全球有几个重要的中心，如中国、泰国、斯里兰卡和印度斋普尔。每个中心都有它的属性、定位和挑战。2015年，美国宝石学院的一支田野考察队考察了印度斋普尔，全方位走访了其宝石和首饰业：彩色宝石切割、批发业、首饰设计、制造和零售，从制造和商贸角度记录了这个行业的当前状况。

关键词：宝石首饰交易中心切割祖母绿彩色宝石斯里兰卡首饰设计首饰业

动脉粥样硬化血栓形成门诊患者的1年心血管事件发生率

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

世界核心医学期刊文摘（心脏病学分册） 2007年第8期3卷 8-9页

作者： Steg G. bhatt D.L. Wilson P.W.F. 杜媛 Dr. Hpital Bichat-Claude Bernard 46 rue Henri Huchard 75018 Paris France

背景:目前关于社区中动脉粥样硬化血栓形成稳定患者的心血管事件发生率的资料较少。尚未在单个国际性队列中评估确诊冠心病(CAD)、脑血管疾病(CVD)及外周血管疾病(PAD)患者或有上述疾病患病风险者的事件发生率差别。目的:在确诊动脉疾... 详细信息

背景:目前关于社区中动脉粥样硬化血栓形成稳定患者的心血管事件发生率的资料较少。尚未在单个国际性队列中评估确诊冠心病(CAD)、脑血管疾病(CVD)及外周血管疾病(PAD)患者或有上述疾病患病风险者的事件发生率差别。目的:在确诊动脉疾病或有多项动脉粥样硬化血栓形成危险因素的门诊患者中,确定当代国际性的1年心血管事件发生率。

关键词：心血管事件血栓形成外周血管疾病动脉疾病患病风险中评估脑卒中发生率医疗诊所前瞻性队列研

电磁导航支气管镜与CT引导下经皮肺穿刺肺周围结节的队列研究

在线全文

学校读者我要写书评

暂无评论

国际医学放射学杂志 2018年第3期 349-350页

作者： K.M.bhatt Y.K.Tandon R.Graham C.T.Lau J.K.Lempel J.T.Azok 吕晓虹 Department of Radiology Pulmonology and Quantitative Health Sciences Cleveland Clinic

摘要目的比较电磁导航支气管镜(ENB)引导与CT引导下经皮肺穿刺肺结节取样的诊断价值和并发症发生率。材料与方法回顾性分析2013—2015年间149例CT引导下经

关键词：

与经皮冠状动脉介入术使用紫杉醇洗脱支架相关的支架血栓形成风险:荟萃分析

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

世界核心医学期刊文摘(心脏病学分册) 2005年第9期 61-62页

作者： Bavry A.A. Kumbhani D.J. Helton T.J. bhatt D.L. 吴波 Dr.Interventional Cardiol. C. Cleveland Clinic Foundation Dept. of Cardiovascular Medicine 9500 Euclid Avenue Cleveland OH 44195 United States

OBJECTIVES: This study investigated the risk of stent thrombosis associated with the use of paclitaxel-eluting stents(PES) compared to bare-metal stents(BMS). BACKGROUND: Clinical experience with coronary drug-eluting stents(DES) is relatively limited. There is concern that DES used for percutaneous coronary intervention may result in subsequent thrombosis. METHODS: We conducted a meta-analysis on eight trials(total of 13 study arms) in 3,817 patients with coronary artery disease who were randomized to either PES or BMS. RESULTS: As compared with BMS, PES do not increase the hazard for thrombosis up to 12 months(risk ratio[RR]=1.06, 95%confidence interval[CI] 0.55 to 2.04, p=0.86]). There was no evidence of heterogeneity among the studies(chi-square value for Q-statistic=5.90[10 degrees of freedom], p=0.82). Similar results were obtained when the analysis was restricted to trials with a polymeric stent platform(Treatment of de novo coronary disease using a single pAclitaXel elUting Stent[TAXUS] -I, -II, -IV, and -VI)(RR=1.01, 95%CI 0.40 to 2.53, p=0.99), trials with longer lesions(TAXUS-IV and -VI)(RR=0.62, 95%CI 0.2 to 1.91, p=0.41), and trials that used a higher dose of paclitaxel(ASian Paclitaxel-Eluting Stent Clinical trial[ASPECT], European evaLUaTion of paclitaxel Eluting Stents[ELUTES], and DELIVER-I)(RR=1.87, 95%CI 0.52 to 6.81, p=0.34). CONCLUSIONS: Current evidence suggests that standard dose PES do not increase the hazard of stent thrombosis compared to BMS.

关键词：

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

印度斋浦尔全球宝石首饰力量之坦桑石贸易

中国宝石 2017年第5期26卷 112-119页

作者： Andrew Lucas Nirupa bhatt Manoj Singhania Kashish Sachish Sachdeva Tao Hsu Pedro Padua 王丽茹

美国宝石学院的一支田野考察队考察了印度斋普尔，全方位走访了其宝石和首饰行业：彩色宝石切割、批发业、首饰设计、制造和零售，从制造和商贸角度记录了这个行业的当前状况。本期刊发考察队在斋浦尔了解到的坦桑石切磨情况。

关键词：宝石首饰印度贸易桑彩色宝石首饰设计行业制造

氯吡格雷联合阿司匹林与单用阿司匹林预防动脉粥样硬化血栓性事件的比较

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

世界核心医学期刊文摘（心脏病学分册） 2006年第7期2卷 6-7页

作者： bhatt D.L. Fox K.A.A. Hacke W. E.J. Topol 罗亮 Department of Genetics Case Western Reserve University BRB 724 10900 Euclid Ave. Cleveland OH 44106-4955 United States Dr.

BACKGROUND: Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for atherothrombotic events. METHODS: We randomly assigned 15,603 patients with either clinically evident cardiovascular disease or multiple risk factors to receive clopidogrel(75 mg per day) plus low-dose aspirin(75 to 162 mg per day) or placebo plus low-dose aspirin and followed them for a median of 28 months. The primary efficacy end point was a composite of myocardial infarction, stroke, or death from cardiovascular causes. RESULTS: The rate of the primary efficacy end point was 6.8 percent with clopidogrel plus aspirin and 7.3 percent with placebo plus aspirin(relative risk, 0.93; 95 percent confidence interval, 0.83 to 1.05; P=0.22). The respective rate of the principal secondary efficacy end point, which included hospitalizations for ischemic events, was 16.7 percent and 17.9 percent(relative risk, 0.92; 95 percent confidence interval, 0.86 to 0.995; P=0.04), and the rate of severe bleeding was 1.7 percent and 1.3 percent(relative risk, 1.25; 95 percent confidence interval, 0.97 to 1.61 percent; P=0.09). The rate of the primary end point among patients with multiple risk factors was 6.6 percent with clopidogrel and 5.5 percent with placebo(relative risk, 1.2; 95 percent confidence interval, 0.91 to 1.59; P=0.20) and the rate of death from cardiovascular causes also was higher with clopidogrel(3.9 percent vs. 2.2 percent, P=0.01). In the subgroup with clinically evident atherothrombosis, the rate was 6.9 percent with clopidogrel and 7.9 percent with placebo(relative risk, 0.88; 95 percent confidence interval, 0.77 to 0.998; P=0.046). CONCLUSIONS: In this trial, there was a suggestion of benefit with clopidogrel treatment in patients with symptomatic atherothrombosis and a suggestion of harm in patients with multiple risk factors. Overall, clopidogrel plus aspirin was not significantly more effective than aspirin alone

关键词：血栓性疾病联合终点联合小剂量心血管疾病安慰剂死亡发生率亚组高危人群出血发生率随机分